According to a new survey from Consumer Reports, Americans prefer taking drugs to talk therapy to treat their anxiety and depression, with almost 80 percent taking medications to treat these conditions. The survey also found that the most popular class of depression drugs remains SSRIs such as Prozac, while newer, pricier antidepressants were found to be less desirable because of their side effects. The survey of 1,500 readers also showed that patients benefited just as much from therapy,...
Read moreSome of you had requested more news on My Depression Connection. So I scoured the headlines to bring you some topics of interest that we... Read more »
Here’s something I don’t get to say very often – a new mental health study came out that I’m very excited about. A study funded by... Read more »
Over the months I have spent here on My Depression Connection, I have answered a lot of your questions. Many of these questions focus... Read more »
The research adventure continues into two key questions in depression treatment: Are antidepressants safe and effective for kids? And, Will... Read more »
Maybe you have been suffering from anxiety related problems for awhile. You have tried meditation, yoga, deep breathing techniques,... Read more »
New guidelines from the American Psychiatric Association and the American College of Obstetricians say that women who suffer from depression during... Read more »
Two non-drug treatments--cognitive behavior therapy and supportive stress management--seem to be more effective than usual care for treating... Read more »
The U.S. Food and Drug Administration has approved the NeuroStar Transcranial Magnetic Stimulation (TMS) system for use in people who suffer from... Read more »
Source: ADAM Encyclopedia
PsychotherapyAmong the various psychotherapeutic "talk therapies," cognitive-behavioral therapy appears to be the most effective approach. If... Read more »
When the U.S. Food and Drug Administration approved Cyberonic's Vagus Nerve Stimulation device for treatment-resistant depression, the agency asked... Read more »